RBC Capital Sticks to Their Hold Rating for Omega Healthcare (OHI)
In a report released yesterday, Michael Carroll from RBC Capital maintained a Hold rating on Omega Healthcare, with a price target of $47.00. The company’s shares closed yesterday at $44.79.
Valentine's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Carroll is a 5-star analyst with an average return of 7.5% and a 61.48% success rate. Carroll covers the Real Estate sector, focusing on stocks such as Alexandria Equities, EPR Properties, and Lineage, Inc..
Currently, the analyst consensus on Omega Healthcare is a Moderate Buy with an average price target of $47.89, implying a 6.92% upside from current levels. In a report released yesterday, Bank of America Securities also reiterated a Hold rating on the stock with a $48.00 price target.
Based on Omega Healthcare’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $319.22 million and a net profit of $171.97 million. In comparison, last year the company earned a revenue of $279.32 million and had a net profit of $113.34 million
Read More on OHI:
Disclaimer & DisclosureReport an Issue
- Omega Healthcare Investors: Rising Operational and Earnings Risk as RIDEA Expansion Increases Dependence on Third-Party Managers
- Omega Healthcare Investors Signals Confident 2026 Earnings Path
- Omega Healthcare price target raised to $52 from $51 at UBS
- Omega Healthcare sees FY26 AFFO $3.15-$3.25, consensus $3.26
- Omega Healthcare reports Q4 AFFO 80c, consensus 79c
